This 5-day courses aims to bring state-of-the-art reviews on the environment, concepts and tools of phenotyping of Genetically Engineered Mice (GEMs). The courses contents have been designed to suit needs of pathologists and scientists using genetically engineered mice in biomedical research. These courses are also suitable for pathology residents preparing for ECVP or ACVP board certification. Invited speakers are internationally recognized experts in the field.

O r g a n i z i n g   C o m m i t t e e

Yan CHEREL, Veterinary School of Nantes (France)
Laurence FIETTE, Platform of Veterinary Diagnosis, Geneva, (Switzerland)
Mohamed SLAOUI, Sanofi-Aventis, Vitry-sur-Seine (France)
Monique WYERS, Veterinary School of Nantes (France).

P r o g r a m s

	EuroGems 2002 program
	EuroGems 2005 program

EuroGems 2002 program

HOW TO MAKE TRANSGENICS & KNOCKOUTS? HOW TO CHECK THE PHENOTYPE? Download it!   GENETIC ENGINEERING: PRINCIPLES & APPLICATIONS Patrick HARDY, Charles River Laboratories - Iffa Credo, L’Arbresle, France BEHAVIORAL PHENOTYPING OF TRANSGENIC & KNOCKOUT MICE Noëlle CALLIZOT, Neurofit, Illkirch, France PHENOTYPING MICE USING MAGNETIC RESONANCE IMAGING (M.R.I.) Robert R. MARONPOT, N.I.E.H.S. / N.I.H., North Carolina, U.S.A. PATHOLOGY OF GEMS   PHENOTYPING GENETICALLY ENGINEERED MICE: Basic principles, protocols & background lesions Jerry M. WARD, N.C.I., N.I.H., Frederick, U.S.A. BACKGROUND DISEASES OF GENETICALLY MODIFIED MICE John P. SUNDBERG, The Jackson Laboratory, Bar Harbor, U.S.A. PATHOLOGY OF THE SKIN John P. SUNDBERG, The Jackson Laboratory, Bar Harbor, U.S.A. PATHOLOGY OF THE LIVER Robert R. MARONPOT, N.I.E.H.S. / N.I.H., North Carolina, U.S.A. EMBRYOLOGY   GROSS & MICROSCOPIC ANATOMY OF THE MOUSE EMBRYO: METHODS FOR HANDLING EMBRYOS. Matthew H. KAUFMAN, University of Edinburgh, Scotland GESTATIONAL MORTALITY Jerry M. WARD, N.C.I., N.I.H., Frederick, U.S.A. HOX GENES KNOCKOUT MICE Yann HERAULT, C.N.R.S., Orléans, France GENE TECHNOLOGY TO UNDERSTAND MOLECULAR EMBRYOLOGY Shahragim TAJBAKHSH, Institut Pasteur, Paris, France GENETICALLY ENGINEERED MICE MODELS TO STUDY CEREBELLAR DEVELOPMENT Marion WASSEF, Ecole Normale Supérieure, Paris, France USE OF GEMS TO STUDY NERVOUS SYSTEM DISEASES & CANCER   RESULTS FROM HISTOPATHOLOGICAL EVALUATION OF P53+/- MICE SERVING AS POSITIVE CONTROLS IN SHORT TERM CARCINOGENICITY BIOASSAYS Matthias Rinke, Bayer AG, Wuppertal, Germany GENETICALLY ENGINEERED MICE AS HUNTINGTON DISEASE MODELS Emmanuel BROUILLET, Service Hospitalier Frédéric Joliot, Orsay, France GENETICALLY ENGINEERED MICE AS ALZHEIMER DISEASE MODELS Laurent PRADIER, Neurodegenerative Disease Group, Aventis Pharma, Vitry-sur-Seine, France MOUSE MODELS OF HUMAN CANCER & TUMOR CLASSIFICATIONS Jerry M. WARD, N.C.I., N.I.H., Frederick, U.S.A. GENETICALLY ENGINEERED MICE AS CANCER MODELS Thierry MOLINA, INSERM, EPI 99-12, Hôtel-Dieu, Paris, France